Showing results (51-60 of 840) with videos related to
Sort By:
Pageof 84
Journal of Neural Transmission (Vienna, Austria : 1996)|May 22, 2007
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?S Bender, M Weisbrod, F ReschThe American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R BrunnerExpert Review of Cardiovascular Therapy|August 1, 2008
Under pressure: future prospects in hypertension management. Interview by Laura DormerHans R BrunnerHospital Practice (Office Ed.)|August 15, 1990
The renin-angiotensin system in hypertension: an updateH R BrunnerJournal of Human Hypertension|April 23, 2002
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overviewHans R BrunnerVascular Health and Risk Management|February 28, 2007
Olmesartan medoxomil: current status of its use in monotherapyHans R BrunnerAmerican Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R BrunnerAmerican Journal of Hypertension|June 2, 1998
Endothelin inhibition as a biologic target for treating hypertensionH R BrunnerPraxis Der Kinderpsychologie Und Kinderpsychiatrie|September 17, 1998
[Operationalized psychodynamic diagnosis in childhood and adolescence--a contribution to quality assurance]F Resch, M Schulte-Markwort, D BürginPageof 84